Programmed Cell Death Ligand 1 Immunohistochemical Expression and Cutaneous Melanoma: A Controversial Relationship
International Journal of Molecular Sciences · 04.01.2024 · 25 (1) · 676
DOI: 10.3390/ijms25010676 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.01.2024. Verfasst von Vincenzo Fiorentino und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, 98125 Messina, Italy. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cutaneous melanoma (CM) is traditionally considered one of the most “immunogenic” tumors, eliciting a high immune response. However, despite the presence of tumor-infiltrating lymphocytes (TILs), melanoma cells use strategies to suppress antitumor immunity and avoid being eliminated by immune surveillance. The PD-1 (programmed death-1)/PD-L1 (programmed death-ligand 1) axis is a well-known immune escape system adopted by neoplastic cells. Therefore, immunotherapy with PD-1 and PD-L1 inhibitors is quickly becoming the main treatment approach for metastatic melanoma patients. However, the clinical utility of PD-L1 expression assessment in CM is controversial, and the interpretation of PD-L1 scores in clinical practice is still a matter of debate. Nonetheless, the recent literature data show that by adopting specific PD-L1 assessment methods in melanoma samples, a correlation between the expression of such a biomarker and a positive response to PD-1-based immunotherapy can be seen. Our review aims to describe the state-of-the-art knowledge regarding the prognostic and predictive role of PD-L1 expression in CM while also referring to possible biological explanations for the variability in its expressions and related treatment responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, 98125 Messina, Italy.
- Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, University of Messina, 98125 Messina, Italy.
- Department of Women, Children and Public Health Sciences, Catholic University of the Sacred Heart, Agostino Gemelli IRCCS University Hospital Foundation, 00168 Rome, Italy.
- Department of Sciences for Promotion of Health and Mother and Child Care, Anatomic Pathology, University of Palermo, 90133 Palermo, Italy.
ORCID-Profile: Vincenzo Fiorentino, Mariausilia Franchina, Maria Lentini
Zitieren
APA
Fiorentino, V., Pizzimenti, C., Franchina, M., Pepe, L., Russotto, F., Tralongo, P., Micali, M. G., Militi, G. B., & Lentini, M. (2024). Programmed Cell Death Ligand 1 Immunohistochemical Expression and Cutaneous Melanoma: A Controversial Relationship. International Journal of Molecular Sciences, 25(1), 676. https://doi.org/10.3390/ijms25010676
Vancouver
Fiorentino V, Pizzimenti C, Franchina M, Pepe L, Russotto F, Tralongo P, et al. Programmed Cell Death Ligand 1 Immunohistochemical Expression and Cutaneous Melanoma: A Controversial Relationship. International Journal of Molecular Sciences. 2024;25(1):676. doi:10.3390/ijms25010676
BibTeX
@article{Fiorentino2024,
author = {Fiorentino, Vincenzo and Pizzimenti, Cristina and Franchina, Mariausilia and Pepe, Ludovica and Russotto, Fernanda and Tralongo, Pietro and Micali, Marina Gloria and Militi, Gaetano Basilio and Lentini, Maria},
title = {Programmed Cell Death Ligand 1 Immunohistochemical Expression and Cutaneous Melanoma: A Controversial Relationship},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {1},
pages = {676},
doi = {10.3390/ijms25010676}
}
EUVIMED